Alzheimer’s disease (AD), a heterogeneous, neurodegenerative condition with an insidious onset and slow progression, is the leading cause of disability and morbidity as well as the sixth-leading cause of death in the United States. Diagnosing AD is often challenging, and multimodal imaging strategies and other novel and emerging biomarkers can aid in differential diagnosis. Currently only symptomatic therapies are available, but recent clinical trials investigating disease-modifying therapies (DMTs) that could slow or reverse the progression of AD have shown great promise.
CME Outfitters is pleased to offer accredited CME/CE activities providing expert-led education on the pathogenesis of AD, current diagnostic criteria and guidelines for AD management, recent advances in the development of AD biomarkers, and the latest clinical evidence on emerging therapies.
Looking Ahead: Integrating Emerging Therapies and Tools in Early-Stage Alzheimer's Disease
|
This Live and OnDemand webcast will feature interactive and lively discussion among specialists who treat patients with AD, with a focus on recognizing early-stage symptoms of AD, the potential role of emerging therapies in treating patients with early-stage AD, and integrating multimodal imaging strategies into the diagnostic process. |
Videos and Interactive 3D Models
Interactive 3D Model of Alzheimer's Disease Pathophysiology and Emerging Treatments
Open the model in a new window
- Use the navigation buttons in the lower-right corner of the animated 3D model to move between the 2 chapters and to play or pause the animation sequences.
- To zoom, rotate, or pan, use the CONTROLS MENU or click MORE OPTIONS > Help > 3D Navigation Basics for tips on navigating with your mouse, keyboard, or touchscreen.
- For a tutorial, click the icon for MORE OPTIONS and then select Help from the popup menu.
- To add your own drawings or notes and download your customized images, click MORE OPTIONS and then Open Whiteboard.
Patient Resources
Clinical Practice Guidelines
- McKhann GM, DeKosky ST, Dickson D, et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):263-269
- Albert MS, Knopman DS, Chertkow H, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):270-279
- Petersen RC, Lopez O, Armstrong MJ, et al. Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018;90(3):126-135.